Multiple system atrophy (MSA) is a progressive disorder with limited treatment options. However, recent research has yielded encouraging discoveries into new therapeutic approaches. Current focus centers on addressing the underlying causes of MSA. One strategy under investigation involves pharmacological interventions to influence the activity of